A single dose of the lipid-lowerer simvastatin, delivered to an organ donor pre-heart transplant, could decrease postoperative troponin levels in transplant recipients and protect the donor heart against perioperative myocardial ischemic damage.

Pig hearts injected with microRNA-199 could be suitable for human transplants within three years, according to an international group of researchers.

Compared to on-pump CABG, off-pump surgery is associated with lower rates of revascularization and a significantly increased risk of all-cause death at three years, according to an analysis of the EXCEL trial.

The results of a Journal of Cardiovascular Nursing study suggest motivation is the key driver of adherence to secondary prevention measures among women who have CHD and have undergone PCI.

Patients with critical limb ischemia might be better off if they opt for endovascular-first treatment over an open surgical bypass, a Circulation: Cardiovascular Quality and Outcomes study suggests.

Surgery doesn’t improve survival in patients with isolated severe tricuspid regurgitation, researchers have found.

The director of Duke University’s heart transplant program is promoting warm perfusion—a technique that preserves organs more effectively than a traditional cooling box—as a means of expanding the CV donor pool in the U.S.

A federal review of UNC Hospital’s pediatric cardiology unit found “no current deficiencies” in the program just two months after the New York Times published an article suggesting the unit was in “total disarray."